The Procter & Gamble Co. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that it is still subject to various investigations into potential competition law violations in Europe.
In July 2006, French…
Whole Foods Market, Inc. disclosed in its latest quarterly report
on Form 10-Q filed with the U.S. Securities and Exchange
Commission that the Federal Trade Commission ( FTC ) Commissioners
approved the settlement agreement concerning the company’s
acquisition of Wild Oats Markets, Inc.
FTC had…
MetLife Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that as of June 30, 2009, there were approximately 125 sales practices litigation matters pending against the Company.
Over the past several…
The Procter & Gamble Co. is in discussions with German authorities concerning alleged violations of antitrust laws, the company disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission.
During the fiscal year ended…
One of MetLife Inc.’s subsidiaries, MetLife Securities Inc. (MSI), may receive a disciplinary action from from the Financial Industry Regulatory Authority (FINRA), the company disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange…
Linear Technology Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that during fiscal year 2009, the Company and the Appeals Division of the U.S. Internal Revenue Service ( IRS Appeals…
MetLife Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on June 3, 2009, the defendant in the lawsuit styled Travelers Ins. Co., et al. v. Banc of America Securities…
One of MetLife Inc.’s subsidiaries, MetLife Securities Inc. (MSI), remains a defendant in two regulatory matters brought by the Illinois Department of Securities, the company disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice regarding a probe centered on its Vioxx product activities.
The…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with governmental entities in Europe in their respective investigations on the company’s Vioxx product.
Investigations are…